Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas
Clinical trial NCT02675439 · TERMINATED
Trial details
- NCT number
- NCT02675439
- Sponsor
- Chinook Therapeutics, Inc. (formerly Aduro)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-28
- Primary completion
- 2019-12-11
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.